Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optive for Ocular Discomfort After Intravitreal Injection
NCT02806830Completed
- Sponsor
- Centre Hospitalier Intercommunal de Créteil
- Start
- Apr 2016
- Primary completion
- Jan 2017
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of carboxymethylcellulose sodium + glycerin in Ocular discomfort, sponsored by Centre Hospitalier Intercommunal de Créteil. Primary endpoint: Ocular discomfort questionnaire score at 72 hours. Started Apr 2016; status: completed.
02
Drugs
carboxymethylcellulose sodium + glycerin
03
Conditions
Ocular discomfort
Beyond the preview
Go deeper on NCT02806830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02806830.